Section of Gynecologic Oncology

  • Our Gynecologic Oncology Faculty

    From left: Drs. Nita Lee, Josephine Kim, John Moroney, Ernst Lengyel, and S. Diane Yamada (Section Chief).

The Section of Gynecologic Oncology at UChicago Medicine under the leadership of Dr. Diane Yamada provides the best possible care for women with the full range of gynecologic cancers. Our Section offers innovative treatments, including minimally invasive surgery with the DaVinci robotic system for endometrial and cervical cancer. We also perform radical trachelectomies to preserve fertility in young women with early cervical cancer.

Dr. Nita Lee, who is an expert in the treatment of endometrial cancer and surgery in obese patients, has created a comprehensive care program that provides our patients with access to behavioral therapy, enabling them to alter habits and develop coping mechanisms.  Our multi-disciplinary Program in Integrative Sexual Medicine (PRISM) for Women and Girls with Cancer, led by Dr. Stacey Lindau, addresses sexual health concerns in female cancer patients and survivors. Dr. John Moroney has worked with Dr. Gini Fleming from the Section of Hematology/ Oncology to develop and open a pipeline to early stage clinical trials, which gives our patients access to novel treatments. Dr. Rebecca Brooks works closely with Dr. Turaga from the Section of Surgical Oncology to offer hyperthermic intraperitoneal chemotherapy (HIPEC) for the surgical treatment of recurrent mucinous cancers.  Additionally, Dr. Iris Romero, a general gynecologist and cancer researcher, and Dr. Shari Snow, the chief of our Section of Gynecology and Minimally Invasive Surgery, have established a cancer risk program to counsel women at high risk for developing gynecologic cancers. We also have a new faculty member, Dr. Josephine Kim, who brings with her a keen interest in quality improvement and surgical outcomes research.

Our clinical team includes 6 faculty, 3 highly skilled physician assistants, Libbe Hassenfritz, Kathryn Hawley, and Kimberly Salminen and 2 chemotherapy nurses, Julie Lutz and Connie Stewart, who have had decades of experience caring for our patients.  The entire team meets weekly for “tumor board” with Gynecologic Pathology, Radiology, and Medical Oncology attending physicians, to share information and insights that lead to the most effective treatments for our patients.

Our Section has an extensive research program focusing on the biology of ovarian cancer and on obesity and endometrial cancer. Our ovarian cancer research laboratory is dedicated to understanding the biology of metastasis. Recently, we have explored the use of highthroughput screening to identify novel drugs that can improve the treatment of patients suffering from cancer. Our members have received research funding from many highly competitive sources, including the National Institutes of Health and the Ovarian Cancer Research Fund. Additionally, our Section offers innovative clinical trials to give our patients access to novel treatments.

Section faculty are responsible for educating students and residents in the diagnosis and treatment of gynecologic cancers, and have consistently demonstrated excellence in teaching.  With our colleagues at NorthShore University HealthSystem, we offer a highly competitive, ABOG-approved Fellowship training program in Gynecologic Oncology, which began in 2010.


Diane Yamada, MD
Joseph Bolivar DeLee Professor of Obstetrics/Gynecology
Chief, Section of Gynecologic Oncology